文献速递重症综合管理与镇静镇痛呼吸衰竭与机械通气

丙泊酚与咪达唑仑在急诊科程序性镇静中的疗效与安全性研究

Propofol versus midazolam for procedural sedation in the emergency department: A study on efficacy and safety.
PubMed 文献 · Am J Emerg Med · 2017-01-03
一句话结论多中心回顾性队列显示,急诊程序性镇静中丙泊酚比咪达唑仑成功率更高、镇静更深、时间更短,呼吸暂停更多但临床相关低氧更少。

该多中心回顾性队列研究纳入荷兰5家医院急诊科4年内的592例程序性镇静,比较丙泊酚(n=284,中位剂量75mg)与咪达唑仑(n=308,中位剂量4mg)的疗效与安全性。丙泊酚组达到更深镇静的比例更高(45% vs 25%,p<0.001),操作成功率更高(92% vs 81%,p<0.001),中位镇静持续时间更短(10 vs 17分钟,p<0.001)。安全性方面,丙泊酚组呼吸暂停更常见(20% vs 10%,p=0.004),而咪达唑仑组临床相关氧饱和度下降(<90%)更常见(8% vs 1%,p=0.001)。作者结论认为丙泊酚在急诊程序性镇静中比咪达唑仑更有效且至少同样安全。

要点

  • 丙泊酚组操作成功率92% vs 咪达唑仑组81%(p<0.001),镇静持续时间中位10 vs 17分钟(p<0.001)。
  • 丙泊酚组达到深镇静比例45% vs 咪达唑仑组25%(p<0.001)。
  • 丙泊酚组呼吸暂停发生率20% vs 咪达唑仑组10%(p=0.004)。
  • 咪达唑仑组临床相关氧饱和度下降(<90%)发生率8% vs 丙泊酚组1%(p=0.001)。
  • 共登记112次镇静事件(99例患者),以短暂呼吸暂停最常见(n=73)。

适用人群与场景

  • 荷兰5家医院急诊科4年内接受程序性镇静的患者,共592例镇静。
  • 丙泊酚组284例,咪达唑仑组308例。

处置流程与药物剂量

  • 丙泊酚镇静中位剂量75mg;咪达唑仑镇静中位剂量4mg。

红旗征与不能漏的情况

  • 短暂呼吸暂停是最常见镇静事件(n=73),丙泊酚组更常发生(20% vs 10%,p=0.004)。
  • 临床相关氧饱和度下降(<90%)在咪达唑仑组更常见(8% vs 1%,p=0.001)。
  • 气道梗阻经简单手法可缓解(n=13),低血压(n=6)。

研究设计与关键结果

  • 多中心回顾性队列研究,纳入荷兰5家医院急诊科4年内592例程序性镇静,比较丙泊酚(n=284,中位剂量75mg)与咪达唑仑(n=308,中位剂量4mg)。
  • 丙泊酚组深镇静比例45% vs 咪达唑仑组25%(p<0.001)。
  • 丙泊酚组操作成功率92% vs 咪达唑仑组81%(p<0.001)。
  • 丙泊酚组中位镇静持续时间10分钟 vs 咪达唑仑组17分钟(p<0.001)。
  • 共登记112次镇静事件(99例患者):短暂呼吸暂停n=73,氧饱和度下降n=18,气道梗阻经简单手法缓解n=13,低血压n=6。
  • 丙泊酚组呼吸暂停发生率20% vs 咪达唑仑组10%(p=0.004);咪达唑仑组临床相关氧饱和度下降(<90%)发生率8% vs 丙泊酚组1%(p=0.001)。

证据类型、等级与局限

  • 证据类型:多中心回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论认为,丙泊酚在急诊程序性镇静中比咪达唑仑更有效且至少同样安全。
  • 丙泊酚镇静需注意呼吸暂停发生率高(20% vs 10%),咪达唑仑镇静需注意临床相关氧饱和度下降发生率高(8% vs 1%)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Procedural sedation for painful procedures in the emergency department (ED) can be accomplished with various pharmacological agents. The choice of the sedative used is highly dependent on procedure- and patient characteristics and on personal- or local preferences.

METHODS: We conducted a multicenter retrospective cohort study of procedural sedations performed in the EDs of 5 hospitals in the Netherlands over a 4year period to evaluate the efficacy- (success rate of the intended procedure) and safety (incidence of sedation (adverse) events) of propofol sedations compared to midazolam sedations.

RESULTS: A total of 592 ED sedations were included in our study. Patients sedated with propofol (n=284, median dose 75mg) achieved a deeper level of sedation (45% vs. 25% deep sedation, p<0.001), had a higher procedure success rate (92% vs. 81%, p<0.001) and shorter median sedation duration (10 vs. 17min, p<0.001) compared to patients receiving midazolam (n=308, median dose 4mg). A total of 112 sedation events were registered for 99 patients. Transient apnea was the most prevalent event (n=73), followed by oxygen desaturation (n=18) airway obstruction responsive to simple maneuvers (n=13) and hypotension (n=6). Propofol sedations were more often associated with the occurrence of apnea's (20% vs. 10%, p=0.004), whereas clinically relevant oxygen desaturations (<90%) were found more often in patients sedated with midazolam (8% vs. 1%, p=0.001). No sedation adverse events were registered CONCLUSION: Propofol is more effective and at least as safe as midazolam for procedural sedation in the ED.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Lameijer H, Sikkema YT, Pol A, et al. Propofol versus midazolam for procedural sedation in the emergency department: A study on efficacy and safety. Am J Emerg Med. 2017. PMID: 28073611. doi:10.1016/j.ajem.2016.12.075

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。